None listed
Conditions
Interventions
Drug : In this trial, we are planning to give intravenous ferric carboxymaltose 1000-1500mg in women who have postpartum anemia after delivery (case group) and compare the maternal depression mood wit
Sponsors
Soon Chun Hyang University Hospital Seoul
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. 19 to 45 years old of postpartum women who have IDA after term delivery (regardless of delivery mode [i.e., elective Cesarean section, normal vaginal delivery, emergency Cesarean section]) and 2. Hb level is 8 g/dL or more and less than 11 g/dL on PP 1~3 days and 3. EPDS score to = 8 on PP 1~3 day 4. Ferritin level is less than 30 ng/ml or transferrin saturation is less than 20% on PP 1~3 days.
Exclusion criteria
Exclusion criteria: ? Postpartum women who had ever had an intravenous injection of iron in the past 3 months. ? Postpartum women whose Hb level on 3rd postpartum day is less than 8g/dL ? Previous experience of adverse events with intravenous iron injection. ? A previously diagnosed woman with mood disorder includes pre-existing depression ? Patients with researchers has been determined to be not appropriate to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of maternal depression mood with EPDS questionnaire at 8 weeks of post delivery, EPDS score Change from baseline to 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| the measured depression rate on postpartum 8 weeks in EPDS score to <8;Change of Fatigue score and EPDS score;Hb, ferritin, transferrin saturation;Adverse events after IV ferric carboxymaltose 1000mg | — |
Countries
Korea, Republic of
Contacts
Public ContactJeong-Won Oh
Soon Chun Hyang University Hospital Seoul
Outcome results
None listed